Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.11 USD | +5.66% | +8.16% | -2.61% |
Mar. 06 | Vanda Pharmaceuticals : FDA Rejects Hetlioz Expanded Label | DJ |
Mar. 06 | Vanda Pharmaceuticals Announces FDA Update for Supplemental NDA for HETLIOZ in the Treatment of Insomnia | CI |
- Stock
- Equities
- Stock Vanda Pharmaceuticals Inc. - Nasdaq
- News Vanda Pharmaceuticals Inc.